Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Giuliani Family Office (GGG) is the private investment vehicle for the Giuliani family, heirs to the historic Italian pharmaceutical legacy of Giuliani SpA, founded in 1889. Based in Lugano, Switzerland, the office manages a diverse global portfolio with a primary focus on life sciences, biotechnology, and healthcare innovation. The group leverages over a century of pharmaceutical expertise to provide strategic capital to early and late-stage companies, particularly those specializing in dermatology, gastroenterology, and the human microbiome. In addition to direct equity investments, the family office maintains significant holdings in specialized healthcare venture capital funds and public healthcare equities. Their investment philosophy emphasizes long-term value creation, often taking an active role in supporting the clinical development and commercialization strategies of their portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Giammaria Giuliani family office.